Just days after President Trump signed an executive order to broaden access to psychedelic medicines, the United States ...

Berkeley, California biotech Ray Therapeutics, a specialist in the development of optogenetic therapies for eye disorders, ...

There has been a major data security lapse at the UK Biobank, with "de-identified" data from its 500,000 volunteers listed ...

Armed with new phase 3 data, Novo Nordisk has said it will file for approval of oral formulations of its GLP-1 agonist ...

There has been a major data security lapse at the UK Biobank, with "de-identified" data from its 500,000 volunteers listed ...

Roche has started its financial reporting for 2026 with a 5% fall in first-quarter revenues, hit by the appreciation of the ...

Last year's $2.5 billion acquisition of Dynavax started to deliver, with a 2.1% rise in vaccine sales to €1.3 billion, driven ...

As more pharmaceutical companies put their hats in the GLP-1 race, with names such as Pfizer, Zealand Pharma, and Amgen due ...

Most insight leaders can now see the strategic potential of AI. They understand where it could help them with faster ...

AbbVie's programme of facility announcements in the US has continued with a new 185-acre campus in Durham, North Carolina, ...

The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu – long considered to be a ...

Sarclisa (isatuximab) has been approved in the US since 2020, initially for relapsed/refractory multiple myeloma before ...